Recent studies have shown bone marrow (BM) cells to differentiate into a variety of cell types and to thereby participate in the reconstitution of damaged organs. In the present study, we examined the extent to which BM-derived cells are incorporated into glomeruli during recovery from experimentally induced nephritis. To investigate the localization of BM cells in glomeruli, chimeric mice were prepared by transplanting BM cells from green fluorescent protein (GFP) transgenic mice into wild-type mice. Five weeks later, glomerulonephritis was induced by intravenous injection of Habu snake venom. Groups of mice were then killed every few days for 42 d, and harvested kidney samples were subjected to immunohistochemical and immunoelectron microscopic analyses with the aim of detecting the presence of GFP(ϩ) cells within glomeruli. The kidney's substantial residual functional capacity is almost entirely due to the approximately one million glomeruli present in each kidney at birth. Postnatal neogenesis of nephron units has never been demonstrated, and renal regenerative ability is believed to be poor. Nevertheless, glomerular reconstruction has been observed in animal models of experimental nephritis, as well as in human glomerulonephritis brought on by steroid therapy (1). Thus, although glomeruli are unable to reproduce lost nephron units, the kidney apparently possesses some regenerative capacity at the cellular level. The mechanism remains unknown, however.
The kidney's substantial residual functional capacity is almost entirely due to the approximately one million glomeruli present in each kidney at birth. Postnatal neogenesis of nephron units has never been demonstrated, and renal regenerative ability is believed to be poor. Nevertheless, glomerular reconstruction has been observed in animal models of experimental nephritis, as well as in human glomerulonephritis brought on by steroid therapy (1) . Thus, although glomeruli are unable to reproduce lost nephron units, the kidney apparently possesses some regenerative capacity at the cellular level. The mechanism remains unknown, however.
In recent studies, investigators were able to induce differentiation of adult stem or progenitor cells (2) into osteocytes, chondrocytes (3), cardiac myocytes (4), vascular endothelial cells (5, 6) , hepatic oval cells (7) and glial cells (8 -11) , but little was discovered about kidney regeneration. Although the relationship between BM stem cells and glomerular mesangial cell regeneration has been examined (12, 13) , the differentiation of progenitor cells into glomerular endothelial cells, which are assumed to be necessary for vascular reconstruction, has not yet been systematically analyzed during regeneration of glomeruli.
The successful isolation of vascular endothelial progenitor cells (5) has made neovascularization using adult stem cells clinically possible (14, 15) . Although differentiation of glomerular endothelial cells from adult stem cells has not yet been achieved, in earlier studies of the role of endothelial cells in the healing process after induction of experimental nephritis, we showed that endothelial cells were indeed regenerated (16, 17) . Since then, we have been interested in whether BM-derived cells participate in the regeneration of glomerular endothelial cells. In that regard, Hayakawa et al. (18) produced a BM chimeric mouse by transplanting BM cells from GFP transgenic mice into normal C57Black6 mice. They used the resultant chimeric animals to investigate regeneration of the small intestine, demonstrating them to be a useful model with which to examine the fate of BM stem cells. More recently, we used these GFP chimeric mice to show that BM-derived cells dif-fluorescence upon deparaffinization, it retains antigenicity, enabling its detailed localization. In similar fashion, we used indirect immunoperoxidase staining with anti-TM antibody to evaluate BM cell differentiation into endothelial cells. As a negative control, primary antibody was replaced with PBS in some samples.
Immunoelectron microscopy. Kidney tissue obtained 42 d after HSV injection was fixed for 24 h in 20% formalin, embedded in Tissue-Tek O.C.T. compound, frozen in chilled acetone, cut into 6-m sections, and incubated first with anti-GFP antibody overnight at 4°C, and then with horseradish peroxidase-conjugated goat-rabbit IgG F(ab') 2 (BioSource International, Camarillo, CA) for 2 h at room temperature. The sections were then fixed for an additional 5 min in 1% glutaraldehyde, reacted with DAB and H 2 O 2 , postfixed in 2% osmium tetroxide for 60 min, dehydrated in a graded ethanol series, and embedded in Epon 812 resin. Ultrathin sections were observed using a transmission electron microscope (model H 7100; Hitachi Ltd., Tokyo, Japan) at 75 kV with either no counterstaining or slight counterstaining with lead citrate.
Urinary protein. Urine spontaneously voided by each animal was collected for 24 h in a metabolic cage on the day before sacrifice. Proteinuria was then measured as the ratio of albumin (mg/dL) to creatinine (mg/dL) in the collected samples. Urinary albumin was measured with a Behring nephrometer (Dade Behring, Marburg, Germany) using anti-mouse albumin antibody (Valeant Pharmaceuticals, Costa Mesa, CA); creatinine was measured with a Hitachi 7170 autoanalyzer (SRL, Tokyo, Japan).
Statistical analysis. All data are presented as group means Ϯ SEM. Means were compared using t tests. Values of p Ͻ 0.05 were considered significant.
RESULTS

Proteinuria.
There was no significant difference in urinary albumin (normalized to creatinine levels) between control BMtransplanted and wild-type C57BL6 mice [0.048 Ϯ 0.004 (n ϭ 5; 5 wk after BMT) versus 0.043 Ϯ 0.002 (n ϭ 5; 13-wk-old mice) (p Ͻ 0.01)]. By contrast, urinary protein levels were significantly higher in HSV-injected mice than in control mice during the acute phase of HSV-induced glomerulonephritis (d 1-3 after injection) (Fig. 1) . No difference in the levels of Evaluation of BM cells after transplantation. After BM transplantation, mice were killed weekly for 5 wk, and GFP expression in BM and PB cells was evaluated by flow cytometry. We found that within 1 wk after BM transplantation, donor-derived GFP(ϩ) cells accounted for 95.70% of BM cells; within 5 wk, 99.50% of PB cells had been replaced with donor-derived GFP(ϩ) cells. These mice were therefore deemed to be a successful chimeric model, as described previously (18, 19) .
In addition, many GFP-positive PB cells (96.2% 1 mo after BMT) differentiated into Mac-1/Gr1 (23.4 Ϯ 0.9%), CD45R/B220 (36.4 Ϯ 1.2%), Thy-1,2 (53.6 Ϯ 2.1%), and NK-1.1(4.7 Ϯ 0.1%) lineages, and the proportion of each lineage in recipient PB was similar to that seen before BM transplantation.
Morphologic assessment of HSV-induced glomerular lesions. The pathologic glomerular alterations observed after injection of HSV were in general agreement with previously published reports (24) (25) (26) , so after preliminary experimentation to determine the appropriate dosage, we used the effects of 2.8 mg/kg of HSV as our glomerulonephritis model in subsequent experiments.
The structural changes that occurred during the healing process after induction of glomerulonephritis are shown in Figure 2 . After HSV administration, 30% of the glomeruli exhibited capillary dilatation and mesangiolytic ballooning during the acute phase (d 1-3). By d 7, mesangial proliferative changes, which were accompanied by mesangial expansion, were observed. These proliferative changes were diminished by d 28, however. And by d 42, no sclerosis or adhesion was present in any of the glomeruli, and Masson-trichrome staining revealed no interstitial fibrosis (Fig. 2f) . Glomeruli from control animals showed no noteworthy histologic changes during the experimental period.
The same nephritis course was seen in the frozen sections, in which numerous GFP(ϩ) cells were observed within glomeruli exhibiting mesangiolytic ballooning during the acute phase (Fig. 3, a and d) . The GFP(ϩ) cells were comprised of platelets and inflammatory cells, which were stained by anti-CD45 or anti-F4/80 antibody. By d 7, when healing of the loop structure of the glomeruli was evident, the numbers of GFP(ϩ) cells within the glomeruli had declined (Fig. 3, b and e) , whereas the numbers had increased in the interstitium surrounding the glomerular lesion. Numbers of interstitial GFP(ϩ) cells continued to increase until d 14, after which they gradually declined until d 42 (Fig. 3, c and f) .
Regeneration of endothelial cells during this time course was examined by immunohistochemical labeling of TM (Fig. 4) . During the acute phase, GFP-TM-double-positive cells were rarely detected within the glomeruli. By d 7, however, the numbers of GFP-TM-double-positive cells-measured as the ratio to the total number of nuclei within glomeruli-were significantly higher than in control mice (Fig. 5) . Still, the proportion of double-positive cells was very low, accounting for only 2.24% of the nuclei present. Moreover, 12 mo after HSV injection, GFP-TM-double-positive cells accounted for 2.11 Ϯ 0.13% of nuclei, which was not significantly different from the level seen at 42 d. And almost all GFP(ϩ)TM(Ϫ) cells in glomerulus were positively stained by both anti-CD45 and anti-F4/80 antigen (Fig. 6) .
Similarly, some GFP(ϩ) cells in the interstitium were also stained by anti-CD45 and anti-F4/80 antigen, though many cells were not stained by one antibody or the other.
Immunohistochemical analysis of paraffin sections. To investigate the localization of GFP in greater detail, paraffin sections were stained with anti-GFP antibody. Seven days after induction of nephritis, GFP(ϩ) cells were evident in the area of the endothelial cells. By d 42, the GFP(ϩ) cells were limited to the area of the endothelial cells and were no longer detected in the epithelial or mesangial areas (Fig. 7) .
Immunoelectron microscopy. The finding that after the HSV-induced nephritis had healed (d 42) GFP was present mainly in glomerular endothelial cells was confirmed by im- 
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munoelectron microscopy using an anti-GFP antibody (Fig. 8) . Not all endothelial cells were GFP(ϩ), however, and GFP(ϩ) blood cells shed into the lumen were also detected within the glomerulus shown. Outside the glomerulus, GFP(ϩ) cells were observed among the endothelial cells of the blood vessel and migratory mononuclear cells (data not shown).
DISCUSSION
We have shown that BM-derived cells differentiate into glomerular endothelial cells during the glomerular healing process after the induction of mouse Habu-venom nephritis. Kitamura et al. (16) previously investigated the regeneration of endothelial cells in a rat model of Habu-venom glomerulonephritis and found that the number of endothelial cells in the glomeruli peaked on d 7, as the numbers of infiltrating inflammatory cells in the mesangiolytic ballooning lesion declined revealing mesangial proliferative changes. TM(ϩ) endothelial cells accounted for 25% of the total glomerular nuclei. In the present study, we found that in our murine model the number of cells positive for both GFP and TM within glomeruli also peaked on d 7, but that the frequency of these cells was very low, indicating that regeneration of endothelial cells cannot be accounted for by BM-derived cells alone. We suggest, therefore, that the regenerated cells were derived primarily from intrinsic glomerular cell components, with BM-derived cells playing a role in endothelial regeneration. This suggestion is supported by the observed long-term survival of BM-derived endothelial cells.
The role of BM cells in glomerular regeneration has also been investigated by Ito et al. (13) using a chimeric rat model. That study showed that, after Thy-1 nephritis, BM-derived cells participate in glomerular regeneration by differentiating into mesangial cells. About the same time. Cornacchia et al. (27) produced a BM-transplanted mouse chimera from which they harvested glomerular cells that were subsequently separated by microdissection and placed in culture. Among the cultured cells, they identified both mesangial and endo- (28) showed that BM cells regenerate both glomerular mesangial and endothelial cells in a rat nephritis model. It is noteworthy, moreover, that they detected the regeneration in rat tissue sections. In the present study, we also detected differentiation of BM cells into glomerular endothelial cells in tissue sections; however, our results differ from those of Rookmaaker and colleagues in several important ways. First, we used a mouse model instead of a rat model. Second, we succeeded in quantifying BM-derived endothelial cells by evaluating the relation between BM cells and glomerular endothelial cells. We suggest that the number of regenerated cells in each glomerulus varies with the magnitude of the lesion and the locus of the glomerulus selected (i.e. surface of the cortex or around the medulla). We therefore considered the number of GFP-TM-double positive cells with respect to the total number of DAPI-stained nuclei per glomerular cross-section. Furthermore, in our experiment, regeneration of glomerular endothelial cells using BM-derived cells was also detected in control mice without nephritis. For that reason, we also compared regeneration of endothelial cells in mice with and without nephritis. Our findings show that over the time course of the experiment the number of regenerated endothelial cells was significantly higher among mice with nephritis than among healthy control mice. Third, our GFP-transplanted mouse model has an advantage over other models in that both the recipient and the donor of the transplant are of the same strain, which means that we did not have to consider the immunologic response to heterologous antigen. Moreover, we were able to observe the behavior of BM-derived cells without immunologic marking. Finally, we used immunoelectron microscopy with an anti-GFP antibody, which enable us to investigate the BM-derived cells in more detail than Rookmaaker et al. (28) were able to.
We think that whether or not endothelial cells are able to proliferate is the most important consideration in glomerulonephritis because that is a key determinant of the progression of glomerular sclerosis. In that regard, the groups of Kitamura (16) and Iruela-Arispe (29) reported that glomeruli are capable of healing after injury when endothelial cells show proliferative responses. In the same vein, Shimizu et al. (17) reported that incomplete capillary repair leads to sclerotic scar lesions in damaged glomeruli. We therefore focused mainly on endothelial regeneration and were able to unequivocally demonstrate differentiation of BM-derived glomerular endothelial cells using both quantitative and electron microscopic analyses.
It was recently reported that, in vitro, BM cells can adopt the phenotype of other cells through spontaneous cell fusion (30) . Our experiments do not exclude the possibility that GFP(ϩ) endothelial cells may have arisen via fusion of recipient endothelial cells and GFP(ϩ) donor BM cells. On the other hand, we would expect the frequency of in vivo cell fusion to be very low, if there is any at all, and transdifferentiation of BM cells into endothelial cells is well documented in other experimental systems (28) . Still, further genetic analysis to determine the origin of each GFP(ϩ) cell would seem appropriate.
Another potential concern is that the act of BM transplantation itself causes renal damage. In the present study, however, transplanted mice exhibited no histologic changes detectable under light microscopy, and proteinuria was not increased. In addition, Gobe et al. (31) showed that many neonatal rat kidney cells become apoptotic during the first day after irradiation. We therefore investigated cell apoptosis of irradiated mouse kidney using 2-d old neonatal (6 Gy) and 8-wk-old adult (10 Gy) C57BL6 mice. We found large numbers of apoptotic cells in neonatal mouse kidneys 5 h after radiation, but we rarely detected apoptotic cells in adult mice kidneys at any time up to 24 h after irradiation (unpublished data). For this reason, we do not believe our model was influenced by 10 Gy radiation.
The future application of these findings may include clarifying the genetics behind the migration of BM cells and their differentiation into endothelial cells. In addition, because these cells remain in the glomerulus once they have differentiated, it may be possible to use BM cells transfected with genes necessary for the treatment of the glomerulus as a gene delivery system. And, ultimately, a full understanding of how differentiation of BM derived cells is regulated in the kidney may mean regeneration of the organ will eventually be possible.
